Implantable System Treats Cause of Chronic Back Pain
|
By HospiMedica International staff writers Posted on 13 Jun 2016 |
|
Image: The implantation site of the ReActiv8 neurostimulator (Photo courtesy of Mainstay Medical).
An innovative implantable neurostimulation system helps treat disabling chronic low back pain (CLBP) via a handheld wireless remote control.
The ReActiv8 is a small implantable neurostimulation system, which excites the nerves responsible for contracting the key muscles that stabilize the lower back. The device is indicated as an adjunct to medical management of CLBP, and for pain relief in adults who have attempted at least on pervious medical management intervention and physical therapy. During the patient-controlled treatment sessions, ReActiv8 stimulation causes repetitive contractions of the key stabilizing muscles, support recovery from CLBP and its related symptoms.
In similar to other exercise programs used to restore muscle control, ReActiv8 is applied twice a day in 30-minute sessions; over time, the stimulated contractions can help the brain and body learn how to restore muscle control and spine stabilization. The ReActiv8 is a product of Mainstay Medical (Dublin, Ireland), and has received the European Community CE mark of approval.
“ReActiv8 is an innovative use of neurostimulation for the treatment of chronic low back pain and the clinical data from the ReActiv8-A trial are compelling,” said neurosurgeon and neurostimulation expert Stefan Schu, MD, of Sana Hospital (Duisburg, Germany). “Neurosurgeons in Germany have a track record of embracing important innovations, and we are looking forward to offering ReActiv8 to patients who until now were facing the prospect of disabling chronic low back pain for the rest of their lives.”
“We see several new chronic low back pain patients every week who are not indicated for surgery, and who meet the indications for ReActiv8,” said Robert Pflugmacher, MD, an orthopedic surgeon at University Hospital Bonn (Germany). “Rather than sending them home untreated, we now have an exciting new option we can offer them. As orthopedic surgeons, ReActiv8 meets our objective of addressing the underlying functional causes of chronic low back pain, and the straightforward implant procedure utilizes skills and techniques familiar to us.”
Related Links:
Mainstay Medical
The ReActiv8 is a small implantable neurostimulation system, which excites the nerves responsible for contracting the key muscles that stabilize the lower back. The device is indicated as an adjunct to medical management of CLBP, and for pain relief in adults who have attempted at least on pervious medical management intervention and physical therapy. During the patient-controlled treatment sessions, ReActiv8 stimulation causes repetitive contractions of the key stabilizing muscles, support recovery from CLBP and its related symptoms.
In similar to other exercise programs used to restore muscle control, ReActiv8 is applied twice a day in 30-minute sessions; over time, the stimulated contractions can help the brain and body learn how to restore muscle control and spine stabilization. The ReActiv8 is a product of Mainstay Medical (Dublin, Ireland), and has received the European Community CE mark of approval.
“ReActiv8 is an innovative use of neurostimulation for the treatment of chronic low back pain and the clinical data from the ReActiv8-A trial are compelling,” said neurosurgeon and neurostimulation expert Stefan Schu, MD, of Sana Hospital (Duisburg, Germany). “Neurosurgeons in Germany have a track record of embracing important innovations, and we are looking forward to offering ReActiv8 to patients who until now were facing the prospect of disabling chronic low back pain for the rest of their lives.”
“We see several new chronic low back pain patients every week who are not indicated for surgery, and who meet the indications for ReActiv8,” said Robert Pflugmacher, MD, an orthopedic surgeon at University Hospital Bonn (Germany). “Rather than sending them home untreated, we now have an exciting new option we can offer them. As orthopedic surgeons, ReActiv8 meets our objective of addressing the underlying functional causes of chronic low back pain, and the straightforward implant procedure utilizes skills and techniques familiar to us.”
Related Links:
Mainstay Medical
Gold Member
12-Channel ECG
CM1200B
New
Medical-Grade Display
HL2316SHTB
New
Syringe Pump
SP50 Series
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
